CPD
The first new smoking cessation aid registered in almost 20 years: a pharmacist’s guide to cytisine
George Krassas, Director and Medical Writer, Scius Healthcare Solutions Reviewed by Dr Brett MacFarlane Cytisine (Cyventine™) is the first new chemical entity registered in Australia to help people quit smoking …
Management of moderate–severe allergic rhinitis
Pharmacists can improve moderate–severe allergic rhinitis management by assessing symptom severity, matching treatment including dual therapy to patient needs, and reinforcing correct nasal spray technique. Shalini Jai Kumar BPharm (Hons), …
Cystic fibrosis management: an update on CFTR modulator therapy
CFTR modulator therapies have transformed cystic fibrosis care by improving the function of defective CFTR protein in people with responsive CFTR variants. Pharmacists should support safe and effective use of …
Chronic hand eczema: a pharmacist’s guide to novel therapy
Chronic hand eczema is a particularly challenging condition for patients who experience ongoing inflammation, itch and pain. Potent topical corticosteroids are often required to control flares, but chronic use may …
Every consultation counts: pharmacist-led counselling, nasal technique and follow-up in allergic rhinitis
A deep dive on what pharmacists can ask, explain, demonstrate and review to improve adherence and outcomes for this highly prevalent condition, including the adjunct use of nasal saline to …
Optimising calcium homeostasis: the interplay of vitamin D, K2, magnesium and calcium in bone density and vascular calcification risk
This article explores the synergistic physiological action of calcium, vitamin D, vitamin K2 and magnesium in bone and cardiovascular health and how supplementation may be beneficial for patients with inadequate …
Introducing AJP Accredited CPD
From March 2026, the AJP will publish CPD activities that meet a rigorous review process known as AJP Accredited CPD The AJP is a well-established and trusted provider of high-quality …
COPD—beyond inhaler therapies with biologics
The emergence of biologic therapies represents one of the most significant advances in COPD management in more than 20 years. Understanding which patients may benefit, how these medicines work, and …
Did it work? Closing the loop on risk management
USING THE PDL RISK MANAGEMENT GUIDE FOR PHARMACISTS This series introduces pharmacists to the PDL Risk Management Guide for Pharmacists, and how it can be used in everyday pharmacy practice …
The autonomic nervous system: what is it and what does it do?
Back to Basics with Peter Carroll The aim of this series of articles is to revisit and discuss some fundamental pharmacological, physiological and therapeutic concepts with the overall objective of …
Bone remodelling and osteoporosis revisited
Back to Basics with Peter Carroll The aim of this series of articles is to revisit and discuss some fundamental pharmacological, physiological and therapeutic concepts with the overall objective of …
The evolving role of pharmacists in implementing treat-to-target gout management
Gout is a common and complex chronic inflammatory arthritis requiring pharmacist expertise to help patients prevent and treat acute flares, manage long-term urate therapy and address risk factors. By Dr …
How risk management supports clinical governance
USING THE PDL RISK MANAGEMENT GUIDE FOR PHARMACISTS This series introduces pharmacists to the PDL Risk Management Guide for Pharmacists, and how it can be used in everyday pharmacy practice …